APA (7th ed.) Citation

A, M., D, S., E, S., G, S., K, A., W, F., . . . R, K. (2015). Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies. Investigational new drugs, 33(5), 1093. https://doi.org/10.1007/s10637-015-0277-8

Chicago Style (17th ed.) Citation

A, Mahipal, Shibata D, Siegel E, Springett G, Almhanna K, Fulp W, Williams-Elson I, and Kim R. "Phase I Trial of Combination of FOLFIRI and Pasireotide, a Somatostatin Analogue, in Advanced Gastrointestinal Malignancies." Investigational New Drugs 33, no. 5 (2015): 1093. https://doi.org/10.1007/s10637-015-0277-8.

MLA (9th ed.) Citation

A, Mahipal, et al. "Phase I Trial of Combination of FOLFIRI and Pasireotide, a Somatostatin Analogue, in Advanced Gastrointestinal Malignancies." Investigational New Drugs, vol. 33, no. 5, 2015, p. 1093, https://doi.org/10.1007/s10637-015-0277-8.